Prelude Therapeutics Inc. (PRLD) Social Stream



Prelude Therapeutics Inc. (PRLD): $17.65

0.13 (+0.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Prelude Therapeutics Inc (PRLD) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Prelude Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $80 $46 $61.6 $17.65 249.01%

The Trend in the Analyst Price Target


PRLD's average price target has moved down $0.9 over the prior 156 days.

Over the past 45 weeks, PRLD's average upside potential has been 36.65%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 5 80 46 61.60 33.80 82.25%
2021-09-19 5 80 46 61.60 35.20 75%
2021-09-18 5 80 46 61.60 35.20 75%
2021-09-11 5 80 46 61.60 32.83 87.63%
2021-09-04 5 80 46 61.60 37.38 64.79%
2021-08-28 5 80 46 61.60 37.57 63.96%
2021-08-14 5 80 46 61.60 32.17 91.48%
2021-08-07 5 80 48 62.00 30.09 106.05%
2021-08-05 5 80 48 62.00 32.43 91.18%
2021-08-01 5 80 48 62.00 32.04 93.51%
2021-07-24 5 80 48 62.00 34.06 82.03%
2021-07-17 5 80 48 62.00 28.39 118.39%
2021-07-10 5 80 48 62.00 28.50 117.54%
2021-07-03 5 80 48 62.00 27.77 123.26%
2021-06-26 5 80 48 62.00 31.90 94.36%
2021-06-13 5 80 48 62.00 31.20 98.72%
2021-06-05 5 80 48 62.00 29.96 106.94%
2021-05-22 5 80 48 62.00 38.72 60.12%
2021-05-15 5 80 48 62.00 42.04 47.48%
2021-05-08 5 80 50 62.40 41.61 49.96%
2021-04-25 4 80 50 62.50 34.59 80.69%
2021-04-17 4 80 50 62.50 32.24 93.86%
2021-04-10 4 80 50 62.50 35.26 77.25%
2021-04-03 4 80 50 62.50 41.25 51.52%
2021-03-20 4 80 50 62.50 54.67 14.32%
2021-03-13 4 80 37 56.00 57.38 -2.41%
2021-03-06 3 60 37 48.00 56.79 -15.48%
2021-02-27 3 60 37 48.00 62.33 -22.99%
2021-02-20 3 60 37 48.00 76.96 -37.63%
2021-02-13 3 60 37 48.00 88.98 -46.06%
2021-02-06 3 60 37 48.00 84.21 -43%
2021-01-30 3 60 37 48.00 64.95 -26.1%
2021-01-23 3 60 37 48.00 74.43 -35.51%
2021-01-16 3 60 37 48.00 74.45 -35.53%
2021-01-09 3 60 37 48.00 66.46 -27.78%
2021-01-02 3 60 37 48.00 71.55 -32.91%
2020-12-26 3 60 37 48.00 88.94 -46.03%
2020-12-19 3 60 37 48.00 76.10 -36.93%
2020-12-10 3 60 37 45.00 59.50 -24.37%
2020-12-07 3 60 37 45.00 49.97 -9.95%
2020-11-28 3 60 37 45.00 47.67 -5.6%
2020-11-20 3 60 37 45.00 51.71 -12.98%
2020-11-12 3 40 37 38.33 42.53 -9.88%

PRLD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 3 1 0 0 5

The Trend in the Broker Recommendations


Over the past 31 weeks, PRLD's average broker recommendation rating improved by 0.8.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Prelude Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 91.54% of all US stocks.
  • Prelude Therapeutics Inc's variance in analysts' estimates is lower than 20.27% of all US stocks.
  • Prelude Therapeutics Inc's average analyst price target is higher than 84.29% of Pharmaceutical Products stocks.
  • Prelude Therapeutics Inc's number of analysts covering the stock is higher than 30.35% of stocks in the mid market cap category.

Stocks similar to Prelude Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AKUS, GLUE and ABOS.

Is PRLD a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7523 seconds.